Invitation to Elekta’s Capital Markets Day – June 19, 2012 in Stockholm

Stockholm, May 3, 2012

Elekta invites equity analysts, investors and media representatives to a Capital Markets Day in Stockholm, June 19. Tomas Puusepp, President and CEO, and other members of Elekta’s management team will give presentations focusing on Elekta’s strategy and development. Lunch will be served from 12:15 CET and the presentations will start at 13:00 and end at approximately 15:30. The venue is Grand Hotel, Stockholm, Sweden.

To attend this Capital Markets Day, please register by e-mail to no later than June 5, 2012.

It will also be possible to follow the Capital Markets Day over the phone and as a live webcast.

Please use the link:

To take part over the phone, please dial in about 5-10 minutes in advance and use the access code: 140085#.

· Sweden: +46 (0)8 506 269 00
· UK : +44 207 750 9905
· US : +1 631 886 5378

We look forward to your participation on June 19.
Best regards,

Stina Thorman                                                           
VP Corporate Communications

Johan Andersson Melbi
Investor Relations Manager                                   

Elisabeth Natt och Dag
Information Manager

For further information, please contact: Johan Andersson Melbi, Investor Relations Manager, Elekta AB. +46 702 100 451,


About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

The following file is available for download

Oct 25, 2016

GenesisCare continues to expand Spanishcancer services with Elekta

Oct 18, 2016

All India Institute of Medical Science expands cancer care with advanced treatment devices from Elekta

Oct 12, 2016

Installation of Elekta’s sixth high-field MR-adaptive linear accelerator initiated at The Christie

Sep 29, 2016

Data presented at ASTRO underscore the promise of Elekta’s high-field MR-adaptive linear accelerator as a transformative advance in radiation therapy

Sep 29, 2016

Elekta and Brainlab improve interoperability and treatment capabilities in stereotactic neurosurgery treatments

Sep 28, 2016

Elekta’s new Leksell Vantage Stereotactic System improves imaging and workflow for neurosurgery procedures

Sep 26, 2016

Elekta informs investors of transformation program and advanced portfolio development at ASTRO Capital Markets presentation

Sep 26, 2016

Elekta’s MOSAIQ Oncology Informatics powers continuous learning to support value-based medicine

Sep 24, 2016

Elekta to continue to help bring radiation treatment to developing countries with nonprofit organization Radiating Hope

Sep 21, 2016

Elekta to highlight High Definition Dynamic Radiosurgery solutions for faster, more precise stereotactic treatments at ASTRO Annual Meeting

Sep 20, 2016

Installation initiated for Elekta’s high-field MR-adaptive linear accelerator at Froedtert & the Medical College of Wisconsin Clinical Cancer Center

Sep 16, 2016

First patient in Switzerland treated with Elekta’s Leksell Gamma Knife Icon